We are live on
!
Find out more
ANI Pharmaceuticals
ANIP
ANIP
67 hedge funds and large institutions have $118M invested in ANI Pharmaceuticals in 2014 Q1 according to their latest regulatory filings, with 41 funds opening new positions, 12 increasing their positions, 6 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
583% more first-time investments, than exits
New positions opened: 41 | Existing positions closed: 6
358% more capital invested
Capital invested by funds: $25.8M → $118M (+$92.4M)
109% more funds holding
Funds holding: 32 → 67 (+35)
100% more repeat investments, than reductions
Existing positions increased: 12 | Existing positions reduced: 6
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Holders
67
Holders Change
+35
Holders Change %
+109.38%
% of All Funds
1.94%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
41
Increased
12
Reduced
6
Closed
6
Calls
$2K
Puts
–
Net Calls
+$2K
Net Calls Change
-$8.38M
Top Buyers
| 1 |
Millennium Management
New York
|
+$12.1M |
| 2 |
DM
Deerfield Management
New York
|
+$9.86M |
| 3 |
CCM
Consonance Capital Management
New York
|
+$6.67M |
| 4 |
LOAMU
Lombard Odier Asset Management (USA)
New York
|
+$6.63M |
| 5 |
CM
Castleark Management
Chicago,
Illinois
|
+$4.76M |
